Ignite Creation Date:
2024-05-06 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05063136
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2021-09-13
Brief Title:
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HRHER2- Primary Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-13
First Submit QC Date:
September 22 2021
Study First Post Date:
2021-09-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-23
Last Update Post Date:
2024-02-26
Last Update Post Date Type:
ACTUAL